Literature DB >> 2971718

Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM.

T Defrance1, B Vanbervliet, J Pène, J Banchereau.   

Abstract

In this report, we describe a novel biologic activity of IL-4 namely, its ability to induce activated human B cells to produce IgM. Staphylococcus aureus Cowan I-activated blasts prepared from high density tonsil B cells were found to secrete IgG and IgM, but no IgE, when cultured in the presence of rIL-4. The differentiating activity of rIL-4 was totally blocked by a neutralizing anti-IL-4 antiserum, therefore demonstrating that the IgG/IgM-inducing activity of rIL-4 was an intrinsic property of IL-4. rIL-4 was only minimally inducing Ig production of blasts prepared from low density B cells, whereas it induced B cell blasts prepared from high density B cells to secrete a high amount of Ig. Delayed additions of the neutralizing anti-IL-4 antiserum demonstrated that a 48-h contact between IL-4 and B cell blasts was required for optimal Ig production. The IL-4-mediated IgG and IgM production was neither suppressed by IFN-gamma nor by anti-CD23 mAb 25, whereas these agents have been shown earlier to inhibit IgE production of enriched B cells cultured in the presence of IL-4. These data indicate that the IgG/IgM-inducing activity of IL-4 is not regulated like the IL-4-induced IgE production by enriched B cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2971718

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Human recombinant erythropoietin directly stimulates B cell immunoglobulin production and proliferation in serum-free medium.

Authors:  H Kimata; A Yoshida; C Ishioka; S Masuda; R Sasaki; H Mikawa
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 2.  Functions of interleukin-4 on human B lymphocytes.

Authors:  J Banchereau; F Rousset
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes.

Authors:  A Ishizaka; Y Sakiyama; M Nakanishi; K Tomizawa; E Oshika; K Kojima; Y Taguchi; E Kandil; S Matsumoto
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

4.  Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; F Rousset; J Pene; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

Review 5.  B cell-cytokine interactions: lessons from clinical immunology.

Authors:  J Farrant; A D Webster
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

Review 6.  Here, there and everywhere: T follicular helper cells on the move.

Authors:  Cindy S Ma; Tri Giang Phan
Journal:  Immunology       Date:  2017-08-07       Impact factor: 7.397

7.  Identification of a cDNA for a human high-molecular-weight B-cell growth factor.

Authors:  J L Ambrus; J Pippin; A Joseph; C Xu; D Blumenthal; A Tamayo; K Claypool; D McCourt; A Srikiatchatochorn; R J Ford
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  Purified excretory-secretory component of filarial parasite enhances Fc epsilon RII/CD23 expression on human splenic B and T cells and IgE synthesis while potentiating T-helper type 2-related cytokine generation from T cells.

Authors:  K A Yamaoka; J P Kolb; N Miyasaka; G Inuo; K Fujita
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

9.  Nonredundant Roles of IL-21 and IL-4 in the Phased Initiation of Germinal Center B Cells and Subsequent Self-Renewal Transitions.

Authors:  David G Gonzalez; Christine M Cote; Jaymin R Patel; Colin B Smith; Yuqi Zhang; Kevin M Nickerson; Tingting Zhang; Steven M Kerfoot; Ann M Haberman
Journal:  J Immunol       Date:  2018-11-16       Impact factor: 5.422

10.  Functional heterogeneity of human T cell clones from atopic and non-atopic donors.

Authors:  C A Chambers; B Zimmerman; N Hozumi
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.